{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:45:11Z","timestamp":1792514711471,"version":"4.5.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41401-025-01629-0","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T10:07:10Z","timestamp":1757671630000},"page":"222-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tigecycline suppresses colon cancer stem cells and impairs tumor engraftment by targeting SNAI1-regulated epithelial-mesenchymal transition"],"prefix":"10.1038","volume":"47","author":[{"given":"Antonio Jes\u00fas","family":"Ruiz-Malag\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Rodr\u00edguez-Sojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailec","family":"Ho-Plagaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Vezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Redondo-Cerezo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Gri\u00f1\u00e1n-Lis\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Marchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Elena","family":"Rodr\u00edguez-Cabezas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Rodr\u00edguez-Nogales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"1629_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"1629_CR2","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67:93\u20139.","journal-title":"CA Cancer J Clin"},{"key":"1629_CR3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-022-05402-9","volume":"611","author":"A Canellas-Socias","year":"2022","unstructured":"Canellas-Socias A, Cortina C, Hernando-Momblona X, Palomo-Ponce S, Mulholland EJ, Turon G, et al. Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells. Nature. 2022;611:603\u201313.","journal-title":"Nature."},{"key":"1629_CR4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev.cellbio.22.010305.104154","volume":"23","author":"NA Lobo","year":"2007","unstructured":"Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol. 2007;23:675\u201399.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"1629_CR5","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nature07602","volume":"457","author":"N Barker","year":"2009","unstructured":"Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature. 2009;457:608\u201311.","journal-title":"Nature."},{"key":"1629_CR6","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1038\/onc.2008.140","volume":"27","author":"V Stemmer","year":"2008","unstructured":"Stemmer V, de Craene B, Berx G, Behrens J. Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene. 2008;27:5075\u201380.","journal-title":"Oncogene."},{"key":"1629_CR7","first-page":"5416923","volume":"2018","author":"LTH Phi","year":"2018","unstructured":"Phi LTH, Sari IN, Yang YG, Lee SH, Jun N, Kim KS, et al. Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment. Stem Cells Int. 2018;2018:5416923.","journal-title":"Stem Cells Int"},{"key":"1629_CR8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.1227670","volume":"339","author":"A Kreso","year":"2013","unstructured":"Kreso A, O\u2019Brien CA, van Galen P, Gan OI, Notta F, Brown AM, et al. Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science. 2013;339:543\u20138.","journal-title":"Science"},{"key":"1629_CR9","doi-asserted-by":"crossref","first-page":"14228","DOI":"10.1073\/pnas.0400067101","volume":"101","author":"C Hirschmann-Jax","year":"2004","unstructured":"Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, et al. A distinct \u201cside population\u201d of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA. 2004;101:14228\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1629_CR10","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/s42003-023-05562-y","volume":"6","author":"S Fujino","year":"2023","unstructured":"Fujino S, Miyoshi N, Ito A, Hayashi R, Yasui M, Matsuda C, et al. Metastases and treatment-resistant lineages in patient-derived cancer cells of colorectal cancer. Commun Biol. 2023;6:1191.","journal-title":"Commun Biol"},{"key":"1629_CR11","doi-asserted-by":"crossref","first-page":"112116","DOI":"10.1016\/j.celrep.2023.112116","volume":"42","author":"D Zhong","year":"2023","unstructured":"Zhong D, Jiang H, Zhou C, Ahmed A, Li H, Wei X, et al. The microbiota regulates hematopoietic stem and progenitor cell development by mediating inflammatory signals in the niche. Cell Rep. 2023;42:112116.","journal-title":"Cell Rep"},{"key":"1629_CR12","doi-asserted-by":"crossref","first-page":"110572","DOI":"10.1016\/j.celrep.2022.110572","volume":"38","author":"X Liu","year":"2022","unstructured":"Liu X, Nagy P, Bonfini A, Houtz P, Bing XL, Yang X, et al. Microbes affect gut epithelial cell composition through immune-dependent regulation of intestinal stem cell differentiation. Cell Rep. 2022;38:110572.","journal-title":"Cell Rep"},{"key":"1629_CR13","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/cancers13050996","volume":"13","author":"M Marzano","year":"2021","unstructured":"Marzano M, Fosso B, Piancone E, Defazio G, Pesole G, De Robertis M. Stem cell impairment at the host-microbiota interface in colorectal cancer. Cancers. 2021;13:996.","journal-title":"Cancers."},{"key":"1629_CR14","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1126\/science.aal5240","volume":"358","author":"S Bullman","year":"2017","unstructured":"Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X, Cai D, et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science. 2017;358:1443\u20138.","journal-title":"Science"},{"key":"1629_CR15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3389\/fonc.2018.00371","volume":"8","author":"Z Zhou","year":"2018","unstructured":"Zhou Z, Chen J, Yao H, Hu H. Fusobacterium and colorectal cancer. Front Oncol. 2018;8:371.","journal-title":"Front Oncol"},{"key":"1629_CR16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/beta-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14:195\u2013206.","journal-title":"Cell Host Microbe"},{"key":"1629_CR17","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1038\/s41388-020-1341-1","volume":"39","author":"W Fong","year":"2020","unstructured":"Fong W, Li Q, Yu J. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer. Oncogene. 2020;39:4925\u201343.","journal-title":"Oncogene."},{"key":"1629_CR18","doi-asserted-by":"crossref","first-page":"114760","DOI":"10.1016\/j.biopha.2023.114760","volume":"163","author":"AJ Ruiz-Malagon","year":"2023","unstructured":"Ruiz-Malagon AJ, Hidalgo-Garcia L, Rodriguez-Sojo MJ, Molina-Tijeras JA, Garcia F, Diez-Echave P, et al. Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response. Biomed Pharmacother. 2023;163:114760.","journal-title":"Biomed Pharmacother"},{"key":"1629_CR19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canlet.2018.04.042","volume":"429","author":"G Jimenez","year":"2018","unstructured":"Jimenez G, Hackenberg M, Catalina P, Boulaiz H, Grinan-Lison C, Garcia MA, et al. Mesenchymal stem cell\u2019s secretome promotes selective enrichment of cancer stem-like cells with specific cytogenetic profile. Cancer Lett. 2018;429:78\u201388.","journal-title":"Cancer Lett"},{"key":"1629_CR20","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1007\/s00394-018-1864-1","volume":"58","author":"M Cruz-Lozano","year":"2019","unstructured":"Cruz-Lozano M, Gonzalez-Gonzalez A, Marchal JA, Munoz-Muela E, Molina MP, Cara FE, et al. Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt\/beta-catenin and TGFbeta signaling pathways. Eur J Nutr. 2019;58:3207\u201319.","journal-title":"Eur J Nutr"},{"key":"1629_CR21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/1878-0261.12635","volume":"14","author":"C Gri\u00f1\u00e1n-Lis\u00f3n","year":"2020","unstructured":"Gri\u00f1\u00e1n-Lis\u00f3n C, Olivares-Urbano MA, Jim\u00e9nez G, L\u00f3pez-Ruiz E, Del Val C, Morata-Tarifa C, et al. miRNAs as radio-response biomarkers for breast cancer stem cells. Mol Oncol. 2020;14:556\u201370.","journal-title":"Mol Oncol"},{"key":"1629_CR22","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37:852\u20137.","journal-title":"Nat Biotechnol"},{"key":"1629_CR23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nmeth.2276","volume":"10","author":"NA Bokulich","year":"2013","unstructured":"Bokulich NA, Subramanian S, Faith JJ, Gevers D, Gordon JI, Knight R, et al. Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nat Methods. 2013;10:57\u20139.","journal-title":"Nat Methods"},{"key":"1629_CR24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jbiotec.2017.06.1198","volume":"261","author":"FO Glockner","year":"2017","unstructured":"Glockner FO, Yilmaz P, Quast C, Gerken J, Beccati A, Ciuprina A, et al. 25 years of serving the community with ribosomal RNA gene reference databases and tools. J Biotechnol. 2017;261:169\u201376.","journal-title":"J Biotechnol"},{"key":"1629_CR25","doi-asserted-by":"crossref","first-page":"D445","DOI":"10.1093\/nar\/gkz862","volume":"48","author":"R Caspi","year":"2020","unstructured":"Caspi R, Billington R, Keseler IM, Kothari A, Krummenacker M, Midford PE, et al. The MetaCyc database of metabolic pathways and enzymes\u2013a 2019 update. Nucleic Acids Res. 2020;48:D445\u2013D53.","journal-title":"Nucleic Acids Res"},{"key":"1629_CR26","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1093\/hmg\/ddi366","volume":"14","author":"C Pena","year":"2005","unstructured":"Pena C, Garcia JM, Silva J, Garcia V, Rodriguez R, Alonso I, et al. E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum Mol Genet. 2005;14:3361\u201370.","journal-title":"Hum Mol Genet"},{"key":"1629_CR27","doi-asserted-by":"crossref","first-page":"e70858","DOI":"10.1371\/journal.pone.0070858","volume":"8","author":"X He","year":"2013","unstructured":"He X, Chen Z, Jia M, Zhao X. Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis. PLoS One. 2013;8:e70858.","journal-title":"PLoS One"},{"key":"1629_CR28","doi-asserted-by":"crossref","first-page":"vii28","DOI":"10.1093\/annonc\/mdx513.004","volume":"28","author":"V Hanu\u0161ov\u00e1","year":"2017","unstructured":"Hanu\u0161ov\u00e1 V, Krbal L, Soukup J, John S, Rudolf E. Role of E-cadherin in metastatic colorectal cancer treatment. Ann Oncol. 2017;28:vii28.","journal-title":"Ann Oncol"},{"key":"1629_CR29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrc1075","volume":"3","author":"P Friedl","year":"2003","unstructured":"Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 2003;3:362\u201374.","journal-title":"Nat Rev Cancer"},{"key":"1629_CR30","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1158\/0008-5472.CAN-13-1349","volume":"74","author":"C Kudo-Saito","year":"2014","unstructured":"Kudo-Saito C, Yura M, Yamamoto R, Kawakami Y. Induction of immunoregulatory CD271+ cells by metastatic tumor cells that express human endogenous retrovirus H. Cancer Res. 2014;74:1361\u201370.","journal-title":"Cancer Res"},{"key":"1629_CR31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-44826-8","volume":"9","author":"V Sundararajan","year":"2019","unstructured":"Sundararajan V, Tan M, Tan TZ, Ye J, Thiery JP, Huang RY. SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition. Sci Rep. 2019;9:8295.","journal-title":"Sci Rep"},{"key":"1629_CR32","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.3390\/cells9081830","volume":"9","author":"TY Huang","year":"2020","unstructured":"Huang TY, Chang TC, Chin YT, Pan YS, Chang WJ, Liu FC, et al. NDAT targets PI3K-mediated PD-L1 upregulation to reduce proliferation in gefitinib-resistant colorectal cancer. Cells. 2020;9:1830.","journal-title":"Cells"},{"key":"1629_CR33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1582-4934.2007.00095.x","volume":"12","author":"H Gali-Muhtasib","year":"2008","unstructured":"Gali-Muhtasib H, Ocker M, Kuester D, Krueger S, El-Hajj Z, Diestel A, et al. Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models. J Cell Mol Med. 2008;12:330\u201342.","journal-title":"J Cell Mol Med"},{"key":"1629_CR34","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer. JAMA. 2021;325:669\u201385.","journal-title":"JAMA."},{"key":"1629_CR35","doi-asserted-by":"crossref","first-page":"995882","DOI":"10.3389\/fmed.2022.995882","volume":"9","author":"L Chen","year":"2022","unstructured":"Chen L, Yang F, Chen S, Tai J. Mechanisms on chemotherapy resistance of colorectal cancer stem cells and research progress of reverse transformation: a mini-review. Front Med. 2022;9:995882.","journal-title":"Front Med"},{"key":"1629_CR36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12929-018-0426-4","volume":"25","author":"AZ Ayob","year":"2018","unstructured":"Ayob AZ, Ramasamy TS. Cancer stem cells as key drivers of tumour progression. J Biomed Sci. 2018;25:20.","journal-title":"J Biomed Sci"},{"key":"1629_CR37","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X, de Reynies A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350\u20136.","journal-title":"Nat Med"},{"key":"1629_CR38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.trecan.2016.07.008","volume":"2","author":"E Fessler","year":"2016","unstructured":"Fessler E, Medema JP. Colorectal cancer subtypes: developmental origin and microenvironmental regulation. Trends Cancer. 2016;2:505\u201318.","journal-title":"Trends Cancer"},{"key":"1629_CR39","doi-asserted-by":"crossref","first-page":"969855","DOI":"10.3389\/fonc.2022.969855","volume":"12","author":"NA Peters","year":"2022","unstructured":"Peters NA, Constantinides A, Ubink I, van Kuik J, Bloemendal HJ, van Dodewaard JM, et al. Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: a proof-of-concept study. Front Oncol. 2022;12:969855.","journal-title":"Front Oncol"},{"key":"1629_CR40","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1073\/pnas.0915135107","volume":"107","author":"TM Yeung","year":"2010","unstructured":"Yeung TM, Gandhi SC, Wilding JL, Muschel R, Bodmer WF. Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci USA. 2010;107:3722\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1629_CR41","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/15384101.2016.1241929","volume":"16","author":"L Zhang","year":"2017","unstructured":"Zhang L, Xu L, Zhang F, Vlashi E. Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer. Cell Cycle. 2017;16:737\u201345.","journal-title":"Cell Cycle"},{"key":"1629_CR42","doi-asserted-by":"crossref","first-page":"619317","DOI":"10.3389\/fonc.2020.619317","volume":"10","author":"H Liu","year":"2021","unstructured":"Liu H, Tao H, Wang H, Yang Y, Yang R, Dai X, et al. Doxycycline inhibits cancer stem cell-like properties via PAR1\/FAK\/PI3K\/AKT pathway in pancreatic cancer. Front Oncol. 2021;10:619317.","journal-title":"Front Oncol"},{"key":"1629_CR43","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00001813-200311000-00001","volume":"14","author":"Z Saikali","year":"2003","unstructured":"Saikali Z, Singh G. Doxycycline and other tetracyclines in the treatment of bone metastasis. Anticancer Drugs. 2003;14:773\u20138.","journal-title":"Anticancer Drugs"},{"key":"1629_CR44","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4252\/wjsc.v11.i7.398","volume":"11","author":"FY Du","year":"2019","unstructured":"Du FY, Zhou QF, Sun WJ, Chen GL. Targeting cancer stem cells in drug discovery: current state and future perspectives. World J Stem Cells. 2019;11:398\u2013420.","journal-title":"World J Stem Cells"},{"key":"1629_CR45","doi-asserted-by":"crossref","first-page":"111285","DOI":"10.1016\/j.biopha.2021.111285","volume":"137","author":"C Sethy","year":"2021","unstructured":"Sethy C, Kundu CN. 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition. Biomed Pharmacother. 2021;137:111285.","journal-title":"Biomed Pharmacother"},{"key":"1629_CR46","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1158\/0008-5472.CAN-18-3544","volume":"79","author":"J Mukohyama","year":"2019","unstructured":"Mukohyama J, Isobe T, Hu Q, Hayashi T, Watanabe T, Maeda M, et al. miR-221 targets QKI to enhance the tumorigenic capacity of human colorectal cancer stem cells. Cancer Res. 2019;79:5151\u20138.","journal-title":"Cancer Res"},{"key":"1629_CR47","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.febslet.2015.01.009","volume":"589","author":"F Liu","year":"2015","unstructured":"Liu F, Kong X, Lv L, Gao J. MiR-155 targets TP53INP1 to regulate liver cancer stem cell acquisition and self-renewal. FEBS Lett. 2015;589:500\u20136.","journal-title":"FEBS Lett"},{"key":"1629_CR48","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1128\/MCB.00941-08","volume":"28","author":"W Kong","year":"2008","unstructured":"Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS, et al. MicroRNA-155 is regulated by the transforming growth factor beta\/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol. 2008;28:6773\u201384.","journal-title":"Mol Cell Biol"},{"key":"1629_CR49","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/ncb2910","volume":"16","author":"WL Hwang","year":"2014","unstructured":"Hwang WL, Jiang JK, Yang SH, Huang TS, Lan HY, Teng HW, et al. MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol. 2014;16:268\u201380.","journal-title":"Nat Cell Biol"},{"key":"1629_CR50","doi-asserted-by":"crossref","first-page":"119035","DOI":"10.1016\/j.lfs.2021.119035","volume":"269","author":"R Rezaei","year":"2021","unstructured":"Rezaei R, Baghaei K, Amani D, Piccin A, Hashemi SM, Asadzadeh Aghdaei H, et al. Exosome-mediated delivery of functionally active miRNA-375-3p mimic regulate epithelial mesenchymal transition (EMT) of colon cancer cells. Life Sci. 2021;269:119035.","journal-title":"Life Sci"},{"key":"1629_CR51","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.bcp.2018.07.044","volume":"155","author":"J Garrido-Mesa","year":"2018","unstructured":"Garrido-Mesa J, Algieri F, Rodriguez-Nogales A, Vezza T, Utrilla MP, Garcia F, et al. Immunomodulatory tetracyclines ameliorate DNBS-colitis: Impact on microRNA expression and microbiota composition. Biochem Pharmacol. 2018;155:524\u201336.","journal-title":"Biochem Pharmacol"},{"key":"1629_CR52","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1111\/bph.14494","volume":"175","author":"J Garrido-Mesa","year":"2018","unstructured":"Garrido-Mesa J, Rodriguez-Nogales A, Algieri F, Vezza T, Hidalgo-Garcia L, Garrido-Barros M, et al. Immunomodulatory tetracyclines shape the intestinal inflammatory response inducing mucosal healing and resolution. Br J Pharmacol. 2018;175:4353\u201370.","journal-title":"Br J Pharmacol"},{"key":"1629_CR53","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1158\/1535-7163.MCT-15-0709","volume":"15","author":"R Yang","year":"2016","unstructured":"Yang R, Yi L, Dong Z, Ouyang Q, Zhou J, Pang Y, et al. Tigecycline inhibits glioma growth by regulating miRNA-199b-5p-HES1-AKT pathway. Mol Cancer Ther. 2016;15:421\u20139.","journal-title":"Mol Cancer Ther"},{"key":"1629_CR54","doi-asserted-by":"crossref","first-page":"14887","DOI":"10.18632\/oncotarget.14841","volume":"8","author":"AA Al-Haidari","year":"2017","unstructured":"Al-Haidari AA, Syk I, Thorlacius H. MiR-155-5p positively regulates CCL17-induced colon cancer cell migration by targeting RhoA. Oncotarget. 2017;8:14887\u201396.","journal-title":"Oncotarget."},{"key":"1629_CR55","first-page":"4781","volume":"15","author":"Y Gao","year":"2018","unstructured":"Gao Y, Liu Z, Ding Z, Hou S, Li J, Jiang K. MicroRNA-155 increases colon cancer chemoresistance to cisplatin by targeting forkhead box O3. Oncol Lett. 2018;15:4781\u20138.","journal-title":"Oncol Lett"},{"key":"1629_CR56","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/1878-0261.13180","volume":"16","author":"JW Park","year":"2022","unstructured":"Park JW, Kim Y, Lee SB, Oh CW, Lee EJ, Ko JY, et al. Autophagy inhibits cancer stemness in triple-negative breast cancer via miR-181a-mediated regulation of ATG5 and\/or ATG2B. Mol Oncol. 2022;16:1857\u201375.","journal-title":"Mol Oncol"},{"key":"1629_CR57","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/annonc\/mdu439","volume":"25","author":"JX Zhang","year":"2014","unstructured":"Zhang JX, Mai SJ, Huang XX, Wang FW, Liao YJ, Lin MC, et al. MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of beta-catenin signaling. Ann Oncol. 2014;25:2196\u2013204.","journal-title":"Ann Oncol"},{"key":"1629_CR58","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1093\/annonc\/mdv302","volume":"26","author":"I Cristobal","year":"2015","unstructured":"Cristobal I, Madoz-Gurpide J, Manso R, Rojo F, Garcia-Foncillas J. MiR-29c downregulation contributes to metastatic progression in colorectal cancer. Ann Oncol. 2015;26:2199\u2013200.","journal-title":"Ann Oncol"},{"key":"1629_CR59","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/sj.onc.1207947","volume":"23","author":"M Al-Hajj","year":"2004","unstructured":"Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene. 2004;23:7274\u201382.","journal-title":"Oncogene."},{"key":"1629_CR60","doi-asserted-by":"crossref","first-page":"33403","DOI":"10.18632\/oncotarget.23607","volume":"9","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Xia L, Wang H, Oyang L, Su M, Liu Q, et al. Cancer stem cells in progression of colorectal cancer. Oncotarget. 2018;9:33403\u201315.","journal-title":"Oncotarget."},{"key":"1629_CR61","doi-asserted-by":"crossref","first-page":"850","DOI":"10.20517\/cdr.2022.20","volume":"5","author":"AR Safa","year":"2022","unstructured":"Safa AR. Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces. Cancer Drug Resist. 2022;5:850\u201372.","journal-title":"Cancer Drug Resist"},{"key":"1629_CR62","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3389\/fonc.2018.00452","volume":"8","author":"C Scatena","year":"2018","unstructured":"Scatena C, Roncella M, Di Paolo A, Aretini P, Menicagli M, Fanelli G, et al. Doxycycline, an inhibitor of mitochondrial biogenesis, effectively reduces cancer stem cells (CSCs) in early breast cancer patients: a clinical pilot study. Front Oncol. 2018;8:452.","journal-title":"Front Oncol"},{"key":"1629_CR63","doi-asserted-by":"crossref","first-page":"40667","DOI":"10.18632\/oncotarget.5842","volume":"6","author":"Y Qin","year":"2015","unstructured":"Qin Y, Zhang Q, Lee S, Zhong WL, Liu YR, Liu HJ, et al. Doxycycline reverses epithelial-to-mesenchymal transition and suppresses the proliferation and metastasis of lung cancer cells. Oncotarget. 2015;6:40667\u201379.","journal-title":"Oncotarget."},{"key":"1629_CR64","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1074\/jbc.M113.528026","volume":"289","author":"A Villarejo","year":"2014","unstructured":"Villarejo A, Cort\u00e9s-Cabrera \u00c1, Molina-Ort\u00edz P, Portillo F, Cano A. Differential role of Snail1 and Snail2 zinc fingers in E-cadherin repression and epithelial to mesenchymal transition. J Biol Chem. 2014;289:930\u201341.","journal-title":"J Biol Chem"},{"key":"1629_CR65","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/cells8101118","volume":"8","author":"C-Y Loh","year":"2019","unstructured":"Loh C-Y, Chai J, Tang T, Wong W, Sethi G, Shanmugam M, et al. The E-Cadherin and N-Cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges. Cells. 2019;8:1118.","journal-title":"Cells."},{"key":"1629_CR66","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/ijc.32644","volume":"146","author":"V Freihen","year":"2020","unstructured":"Freihen V, Ronsch K, Mastroianni J, Frey P, Rose K, Boerries M, et al. SNAIL1 employs beta-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation. Int J Cancer. 2020;146:2229\u201342.","journal-title":"Int J Cancer"},{"key":"1629_CR67","doi-asserted-by":"crossref","first-page":"20768","DOI":"10.3390\/ijms141020768","volume":"14","author":"N Zucchini-Pascal","year":"2013","unstructured":"Zucchini-Pascal N, Peyre L, Rahmani R. Crosstalk between beta-catenin and snail in the induction of epithelial to mesenchymal transition in hepatocarcinoma: role of the ERK1\/2 pathway. Int J Mol Sci. 2013;14:20768\u201392.","journal-title":"Int J Mol Sci"},{"key":"1629_CR68","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/cancers8070060","volume":"8","author":"F de Sousa e Melo","year":"2016","unstructured":"de Sousa e Melo F, Vermeulen L. Wnt signaling in cancer stem cell biology. Cancers. 2016;8:60.","journal-title":"Cancers."},{"key":"1629_CR69","volume":"4","author":"YJ Su","year":"2015","unstructured":"Su YJ, Chang YW, Lin WH, Liang CL, Lee JL. An aberrant nuclear localization of E-cadherin is a potent inhibitor of Wnt\/beta-catenin-elicited promotion of the cancer stem cell phenotype. Oncogenesis. 2015;4:e157.","journal-title":"Oncogenesis."},{"key":"1629_CR70","doi-asserted-by":"crossref","first-page":"314ra186","DOI":"10.1126\/scitranslmed.aac7433","volume":"7","author":"MR Junttila","year":"2015","unstructured":"Junttila MR, Mao W, Wang X, Wang BE, Pham T, Flygare J, et al. Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancer. Sci Transl Med. 2015;7:314ra186.","journal-title":"Sci Transl Med"},{"key":"1629_CR71","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/stem.1233","volume":"30","author":"K Kemper","year":"2012","unstructured":"Kemper K, Prasetyanti PR, De Lau W, Rodermond H, Clevers H, Medema JP. Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells. Stem Cells. 2012;30:2378\u201386.","journal-title":"Stem Cells"},{"key":"1629_CR72","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.3892\/or.2015.3862","volume":"33","author":"D Li","year":"2015","unstructured":"Li D, Yang Z-K, Bu J-Y, Xu C-Y, Sun HUI, Tang J-B, et al. OCT4B modulates OCT4A expression as ceRNA in tumor cells. Oncol Rep. 2015;33:2622\u201330.","journal-title":"Oncol Rep"},{"key":"1629_CR73","volume":"12","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Huang S, Chen S, Chen J, Wang Z, Wang Y, et al. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial\u2013mesenchymal transition by \u03b2-catenin and Beclin1\/autophagy signaling in colorectal cancer. Cell Death Dis. 2021;12:449.","journal-title":"Cell Death Dis"},{"key":"1629_CR74","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3390\/microorganisms9081548","volume":"9","author":"CY Fang","year":"2021","unstructured":"Fang CY, Chen JS, Hsu BM, Hussain B, Rathod J, Lee KH. Colorectal cancer stage-specific fecal bacterial community fingerprinting of the Taiwanese population and underpinning of potential taxonomic biomarkers. Microorganisms. 2021;9:1548.","journal-title":"Microorganisms."},{"key":"1629_CR75","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12866-023-02991-x","volume":"23","author":"RH Khattab","year":"2023","unstructured":"Khattab RH, Abo-Hammam RH, Salah M, Hanora AM, Shabayek S, Zakeer S. Multi-omics analysis of fecal samples in colorectal cancer Egyptians patients: a pilot study. BMC Microbiol. 2023;23:238.","journal-title":"BMC Microbiol"},{"key":"1629_CR76","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","volume":"580","author":"C Pleguezuelos-Manzano","year":"2020","unstructured":"Pleguezuelos-Manzano C, Puschhof J, Rosendahl Huber A, van Hoeck A, Wood HM, Nomburg J, et al. Mutational signature in colorectal cancer caused by genotoxic pks(+) E. coli. Nature. 2020;580:269\u201373.","journal-title":"Nature."},{"key":"1629_CR77","doi-asserted-by":"crossref","DOI":"10.1038\/s41522-024-00479-8","volume":"10","author":"T Zhou","year":"2024","unstructured":"Zhou T, Wu J, Tang H, Liu D, Jeon BH, Jin W, et al. Enhancing tumor-specific recognition of programmable synthetic bacterial consortium for precision therapy of colorectal cancer. NPJ Biofilms Microbiomes. 2024;10:6.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"1629_CR78","volume":"11","author":"CJ Chiang","year":"2021","unstructured":"Chiang CJ, Huang PH. Metabolic engineering of probiotic Escherichia coli for cytolytic therapy of tumors. Sci Rep. 2021;11:5853.","journal-title":"Sci Rep"},{"key":"1629_CR79","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/gt.2008.188","volume":"16","author":"RM Ryan","year":"2009","unstructured":"Ryan RM, Green J, Williams PJ, Tazzyman S, Hunt S, Harmey JH, et al. Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors. Gene Ther. 2009;16:329\u201339.","journal-title":"Gene Ther"},{"key":"1629_CR80","doi-asserted-by":"crossref","first-page":"725583","DOI":"10.3389\/fphar.2021.725583","volume":"12","author":"X Hou","year":"2021","unstructured":"Hou X, Zhang P, Du H, Chu W, Sun R, Qin S, et al. Akkermansia muciniphila potentiates the antitumor efficacy of FOLFOX in colon cancer. Front Pharmacol. 2021;12:725583.","journal-title":"Front Pharmacol"},{"key":"1629_CR81","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/carcin\/bgaa018","volume":"41","author":"GY Koh","year":"2020","unstructured":"Koh GY, Kane AV, Wu X, Crott JW. Parabacteroides distasonis attenuates tumorigenesis, modulates inflammatory markers and promotes intestinal barrier integrity in azoxymethane-treated A\/J mice. Carcinogenesis. 2020;41:909\u201317.","journal-title":"Carcinogenesis."},{"key":"1629_CR82","doi-asserted-by":"crossref","first-page":"153653","DOI":"10.1016\/j.phymed.2021.153653","volume":"90","author":"Y Ji","year":"2021","unstructured":"Ji Y, Tao T, Zhang J, Su A, Zhao L, Chen H, et al. Comparison of effects on colitis-associated tumorigenesis and gut microbiota in mice between Ophiocordyceps sinensis and Cordyceps militaris. Phytomedicine. 2021;90:153653.","journal-title":"Phytomedicine."},{"key":"1629_CR83","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-019-0878-z","volume":"565","author":"T Tanoue","year":"2019","unstructured":"Tanoue T, Morita S, Plichta DR, Skelly AN, Suda W, Sugiura Y, et al. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature. 2019;565:600\u20135.","journal-title":"Nature."},{"key":"1629_CR84","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1007\/DCR.0b013e3181f4b148","volume":"53","author":"L Avram-Hananel","year":"2010","unstructured":"Avram-Hananel L, Stock J, Parlesak A, Bode C, Schwartz B. E durans strain M4-5 isolated from human colonic flora attenuates intestinal inflammation. Dis Colon Rectum. 2010;53:1676\u201386.","journal-title":"Dis Colon Rectum"},{"key":"1629_CR85","doi-asserted-by":"crossref","first-page":"e0159705","DOI":"10.1371\/journal.pone.0159705","volume":"11","author":"T Kanda","year":"2016","unstructured":"Kanda T, Nishida A, Ohno M, Imaeda H, Shimada T, Inatomi O, et al. Enterococcus durans TN-3 induces regulatory T cells and suppresses the development of dextran sulfate sodium (DSS)-induced experimental colitis. PLoS One. 2016;11:e0159705.","journal-title":"PLoS One"},{"key":"1629_CR86","volume":"21","author":"L Zhang","year":"2023","unstructured":"Zhang L, Liu J, Deng M, Chen X, Jiang L, Zhang J, et al. Enterococcus faecalis promotes the progression of colorectal cancer via its metabolite: biliverdin. J Transl Med. 2023;21:72.","journal-title":"J Transl Med"},{"key":"1629_CR87","first-page":"88","volume":"8","author":"P Carasi","year":"2017","unstructured":"Carasi P, Racedo SM, Jacquot C, Elie AM, Serradell ML, Urdaci MC. Enterococcus durans EP1 a promising anti-inflammatory probiotic able to stimulate siga and to increase Faecalibacterium prausnitzii abundance. Front Immunol. 2017;8:88.","journal-title":"Front Immunol"},{"key":"1629_CR88","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3390\/biomedicines10051128","volume":"10","author":"IJ Dikeocha","year":"2022","unstructured":"Dikeocha IJ, Al-Kabsi AM, Chiu HT, Alshawsh MA. Faecalibacterium prausnitzii ameliorates colorectal tumorigenesis and suppresses proliferation of HCT116 colorectal cancer cells. Biomedicines. 2022;10:1128.","journal-title":"Biomedicines."},{"issue":"5","key":"1629_CR89","doi-asserted-by":"crossref","first-page":"e00065","DOI":"10.1128\/mSystems.00065-17","volume":"2","author":"SG Daniel","year":"2017","unstructured":"Daniel SG, Ball CL, Besselsen DG, Doetschman T, Hurwitz BL. Functional changes in the gut microbiome contribute to transforming growth factor beta-deficient colon cancer. mSystems. 2017;2:e00065\u201317.","journal-title":"mSystems."},{"key":"1629_CR90","doi-asserted-by":"crossref","first-page":"1303795","DOI":"10.3389\/fimmu.2023.1303795","volume":"14","author":"EO Gubernatorova","year":"2023","unstructured":"Gubernatorova EO, Gorshkova EA, Bondareva MA, Podosokorskaya OA, Sheynova AD, Yakovleva AS, et al. Akkermansia muciniphila - friend or foe in colorectal cancer? Front Immunol. 2023;14:1303795.","journal-title":"Front Immunol"},{"key":"1629_CR91","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ccell.2022.11.013","volume":"41","author":"H Teng","year":"2023","unstructured":"Teng H, Wang Y, Sui X, Fan J, Li S, Lei X, et al. Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer. Cancer Cell. 2023;41:124\u201338.e6.","journal-title":"Cancer Cell"},{"key":"1629_CR92","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ebiom.2019.11.011","volume":"50","author":"K Zheng","year":"2019","unstructured":"Zheng K, Yu J, Chen Z, Zhou R, Lin C, Zhang Y, et al. Ethanol promotes alcohol-related colorectal cancer metastasis via the TGF-beta\/RUNX3\/Snail axis by inducing TGF-beta1 upregulation and RUNX3 cytoplasmic mislocalization. EBioMedicine. 2019;50:224\u201337.","journal-title":"EBioMedicine."},{"key":"1629_CR93","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-80240-1","volume":"11","author":"M Devall","year":"2021","unstructured":"Devall M, Plummer SJ, Bryant J, Jennelle LT, Eaton S, Dampier CH, et al. Ethanol exposure drives colon location specific cell composition changes in a normal colon crypt 3D organoid model. Sci Rep. 2021;11:432.","journal-title":"Sci Rep"},{"key":"1629_CR94","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15136-9","volume":"11","author":"M Kodama","year":"2020","unstructured":"Kodama M, Oshikawa K, Shimizu H, Yoshioka S, Takahashi M, Izumi Y, et al. A shift in glutamine nitrogen metabolism contributes to the malignant progression of cancer. Nat Commun. 2020;11:1320.","journal-title":"Nat Commun"},{"key":"1629_CR95","first-page":"245","volume":"19","author":"WH Gmeiner","year":"2008","unstructured":"Gmeiner WH, Hellmann GM, Shen P. Tissue-dependent and -independent gene expression changes in metastatic colon cancer. Oncol Rep. 2008;19:245\u201351.","journal-title":"Oncol Rep"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01629-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01629-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01629-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T07:22:49Z","timestamp":1767424969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01629-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1629"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01629-0","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"value":"17 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}